Racial and ethnic disparities in the overall survival of women with epithelial ovarian cancer in Florida, 2001-2015.
Black or African American
/ statistics & numerical data
Aged
Carcinoma, Ovarian Epithelial
/ ethnology
Ethnicity
/ statistics & numerical data
Female
Florida
/ epidemiology
Health Status Disparities
Hispanic or Latino
/ statistics & numerical data
Humans
Male
Middle Aged
Ovarian Neoplasms
/ ethnology
Prevalence
Registries
White People
/ statistics & numerical data
Disparities
Epidemiology
Epithelial ovarian cancer
Race/ethnicity
Survival
Journal
Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
04
09
2019
accepted:
10
02
2020
pubmed:
14
2
2020
medline:
1
7
2020
entrez:
14
2
2020
Statut:
ppublish
Résumé
Many studies have focused on white and black disparities in epithelial ovarian cancer (EOC) but fewer include Hispanics. Florida presents a unique opportunity to study racial/ethnic disparities. This study examined racial/ethnic disparities in the overall survival of women with EOC in Florida by histology. All EOC cases from 2001 through 2015 were identified in the Florida Cancer Database System (FCDS). Survival curves by race/ethnicity and histology were generated by Kaplan-Meier methods. Cox regression evaluated the associations between race/ethnicity, histology, and survival. Eligible EOC cases (n = 21,721) identified in the 2001-2015 FCDS were included in the study. The median survival for non-Hispanic whites (NHWs), non-Hispanic blacks (NHBs), and Hispanics was 31, 21, and 35 months, respectively (p < 0.001). NHB had an increased [AHR 1.23 (95% CI 1.15, 1.30)] and Hispanics a nonsignificant decreased hazard [AHR 0.96 (95% CI 0.91, 1.02)] of death compared to NHW after controlling for other demographic, treatment, and tumor characteristics. Relative to NHWs, NBH had worse survival while Hispanics had equivalent survival. Future research should consider evaluating genetic and epigenetic modifications, and prevalence of cancer syndromes to further elucidate the etiologies of disease in these disparate populations.
Identifiants
pubmed: 32052218
doi: 10.1007/s10552-020-01276-2
pii: 10.1007/s10552-020-01276-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM